NDTV Profit

Sun Pharma Shares


'Sun Pharma Shares' - 135 News Result(s)

  • Sun Pharma, Almirall Enter Pact For Psoriasis Novel Biologic

    Sun Pharma, Almirall Enter Pact For Psoriasis Novel Biologic

    Drug major Sun Pharmaceutical and Spanish firm Almirall have entered into a licensing pact for development and commercialisation of tildrakizumab used for treatment of psoriasis in Europe.

  • SPARC Shares Surge Nearly 8% On Licensing Pact With Sun Pharma

    SPARC Shares Surge Nearly 8% On Licensing Pact With Sun Pharma

    Shares of Sun Pharma Advanced Research Company (SPARC) surged 8 per cent as the company and parent Sun Pharma entered into a licensing deal for Elepsia tablets in the US for upfront payment of $10 million.

  • Sun Pharma Launches Cancer Drug In Europe, Shares Gain

    Sun Pharma Launches Cancer Drug In Europe, Shares Gain

    Drug major Sun Pharmaceutical Industries Ltd on Monday announced the launch of ready-to-administer cancer drug Gemcitabine InfuSMART in Europe.

  • Sun Pharma To Buy Back Shares Worth Rs 675 Crore

    Sun Pharma To Buy Back Shares Worth Rs 675 Crore

    As per Sebi guidelines, 15 per cent of the buyback offer is reserved for shareholders holding equity shares having market value of not more than Rs 2,00,000 as on the record date.

  • Pharma Stocks Outperform; Lupin, Sun Pharma Rise 2%

    Pharma Stocks Outperform; Lupin, Sun Pharma Rise 2%

    Shares of pharmaceutical companies such as Lupin, Sun Pharmaceuticals, Dr Reddy's Laboratories and Aurobindo Pharma outperformed today in an otherwise subdued market.

  • Buy Havells, L&T; Avoid Sun Pharma, Ashok Leyland: Anil Manghnani

    Buy Havells, L&T; Avoid Sun Pharma, Ashok Leyland: Anil Manghnani

    8,243 on Nifty, which is 61.8 per cent retracement of the fall from high of 9,119 hit in March 2015 to low of 6,825 hit in February 2016, is an important level for markets, says Anil Manghnani of Modern Shares and Stock Brokers. The magnitude of rally from lows of 6,825 tells that market was highly oversold, but for a proper rally to continue, the...

  • Sun Pharma Problems To Linger On For 2-3 Quarters: Jefferies

    Sun Pharma Problems To Linger On For 2-3 Quarters: Jefferies

    Headwinds plaguing Sun Pharmaceutical, India's largest drug maker, will continue for the next two-three quarters owing to pricing pressures and regulatory issues dogging its Halol plant, says a report.

  • Sun Pharma Shares Slump On Q4 Profit Miss, Revenue Guidance

    Sun Pharma Shares Slump On Q4 Profit Miss, Revenue Guidance

    Sun Pharmaceutical Industries shares slumped over 5 per cent on Tuesday, following the drugmaker's fourth quarter earnings announcement. Sun Pharmaceutical, India's largest drugmaker, was the top Nifty50 loser today.

  • Sensex Edges Down, But Heads For Third Straight Monthly Gain

    Sensex Edges Down, But Heads For Third Straight Monthly Gain

    Indian shares edged down on Tuesday as investors took profit after five consecutive sessions of gains, but indexes were headed for their third straight monthly rise, outperforming almost all regional markets.

  • Sun Pharma Gets US Summons Over Drug Pricing, Shares Flat

    Sun Pharma Gets US Summons Over Drug Pricing, Shares Flat

    The US Department of Justice (DoJ) on Saturday sought information from Sun Pharma about pricing and marketing of generic drugs that it sells in that country.

  • Sun Pharma Shares Jump On Taro's Q4

    Sun Pharma Shares Jump On Taro's Q4

    Sun Pharmaceuticals shares jumped over 5 per cent on Friday after the drugmaker's US-based subsidiary Taro Pharma reported strong earnings.

  • SPARC Q4 Net Loss Widens To Rs 9.6 Crore

    SPARC Q4 Net Loss Widens To Rs 9.6 Crore

    Sun Pharma Advanced Research Company (SPARC), the pharma research and drug discovery arm of Sun Pharma, on Friday reported a slight increase in its stand-alone net loss at Rs 9.58 crore for the quarter to March 2016.

  • Sun Pharma Shares Hit As Taro Stops Keveyis Sales

    Sun Pharma Shares Hit As Taro Stops Keveyis Sales

    Sun Pharmaceuticals Industries' shares fell nearly 4 per cent on Tuesday after its New York Stock Exchange-listed subsidiary Taro Pharmaceutical stopped commercial sales of Keveyis, a drug used in treatment of periodic paralysis.

  • Sun Pharma Shares Up 2% On USFDA Nod For BromSite

    Sun Pharma Shares Up 2% On USFDA Nod For BromSite

    Sun Pharma stock price rose by nearly 2 per cent on Monday as it received approval from the US health regulator USFDA for its non-steroid drug BromSite used to treat inflammation and prevent pain in patients undergoing cataract surgery.

  • Sun Pharma Rises as Company Buys 14 Brands From Novartis

    Sun Pharma Rises as Company Buys 14 Brands From Novartis

    Shares of Sun Pharma rose by nearly 3 per cent today as the drug major forayed into the Japanese prescription market by acquiring 14 brands from Swiss drug firm Novartis for $293 million (over Rs 1,940 crore).

  • Sensex in Narrow Range Amid Cautious Trade

    Sensex in Narrow Range Amid Cautious Trade

    Indian shares were little changed on Tuesday amid caution ahead of the expiry of monthly derivative contracts later this week and a speech from Federal Reserve Chair Janet Yellen later in the day.

  • Pharma Stocks Reel Under Heat of Government Action

    Pharma Stocks Reel Under Heat of Government Action

    Pharma stocks were under strong selling pressure for second consecutive day, weighed down by a weekend order from the government banning over 300 drugs.

  • Sensex Falls 286 Points on Selloff in Metal Shares

    Sensex Falls 286 Points on Selloff in Metal Shares

    UPL, Sun TV Network, MRPL, Jidal Steel, NALCO, Torrent Pharma, JSW Steel and Glenmark were among the losers from the mid-cap space, down 3-4.6 per cent each.

Advertisement

Advertisement